Newly synthesized Mpro inhibitors as potential oral anti-SARS-CoV-2 agents

被引：0
|
作者：
Lin Li
Shile Huang
机构：
[1] Louisiana State University Health Sciences Center,Department of Biochemistry and Molecular Biology
[2] Louisiana State University Health Sciences Center,Department of Hematology and Oncology
[3] Louisiana State University Health Sciences Center,Feist
来源：
Signal Transduction and Targeted Therapy | / 6卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Potential inhibitors for SARS-CoV-2 Mpro from marine compounds
    Tam, Nguyen Minh
    Pham, Minh Quan
    Nguyen, Huy Truong
    Hong, Nam Dao
    Hien, Nguyen Khoa
    Quang, Duong Tuan
    Thu Phung, Huong Thi
    Ngo, Son Tung
    RSC ADVANCES, 2021, 11 (36) : 22206 - 22213
  • [22] Identification of 3-chymotrypsin like protease (3CLPro) inhibitors as potential anti-SARS-CoV-2 agents
    Mody, Vicky
    Ho, Joanna
    Wills, Savannah
    Mawri, Ahmed
    Lawson, Latasha
    Ebert, Maximilian C. C. J. C.
    Fortin, Guillaume M.
    Rayalam, Srujana
    Taval, Shashidharamurthy
    COMMUNICATIONS BIOLOGY, 2021, 4 (01)
  • [23] Natural Flavonoids as Potential Angiotensin-Converting Enzyme 2 Inhibitors for Anti-SARS-CoV-2
    Muchtaridi, Muchtaridi
    Fauzi, M.
    Ikram, Nur Kusaira Khairul
    Gazzali, Amirah Mohd
    Wahab, Habibah A.
    MOLECULES, 2020, 25 (17):
  • [24] Anti-SARS-CoV-2 Natural Products as Potentially Therapeutic Agents
    Kim, Cheorl-Ho
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [25] 3CL Protease Inhibitors with an Electrophilic Arylketone Moiety as Anti-SARS-CoV-2 Agents
    Konno, Sho
    Kobayashi, Kiyotaka
    Senda, Miki
    Funai, Yuta
    Seki, Yuta
    Tamai, Ikumi
    Schaekel, Laura
    Sakata, Kyousuke
    Pillaiyar, Thanigaimalai
    Taguchi, Akihiro
    Taniguchi, Atsuhiko
    Guetschow, Michael
    Mueller, Christa E.
    Takeuchi, Koh
    Hirohama, Mikako
    Kawaguchi, Atsushi
    Kojima, Masaki
    Senda, Toshiya
    Shirasaka, Yoshiyuki
    Kamitani, Wataru
    Hayashi, Yoshio
    JOURNAL OF MEDICINAL CHEMISTRY, 2022, 65 (04) : 2926 - 2939
  • [26] Molnupiravir-A Novel Oral Anti-SARS-CoV-2 Agent
    Ching-Chi Lee
    Chih-Chia Hsieh
    Wen-Chien Ko
    ANTIBIOTICS-BASEL, 2021, 10 (11):
  • [27] Synthesis of Novel N4-Hydrocytidine Analogs as Potential Anti-SARS-CoV-2 Agents
    Amblard, Franck
    LeCher, Julia C.
    De, Ramyani
    Goh, Shu Ling
    Li, Chengwei
    Kasthuri, Mahesh
    Biteau, Nicolas
    Zhou, Longhu
    Tber, Zahira
    Downs-Bowen, Jessica
    Zandi, Keivan
    Schinazi, Raymond F.
    PHARMACEUTICALS, 2022, 15 (09)
  • [28] Drug repurposing of pyrazolotriazine derivatives as potential anti-SARS-CoV-2 agents: in vitro and in silico studies
    Oudah, Khulood H.
    Najm, Mazin A. A.
    Barghash, Reham F.
    Kutkat, Omnia
    Gaballah, Mohamed
    Albohy, Amgad
    Abouzid, Khaled A. M.
    BMC CHEMISTRY, 2024, 18 (01)
  • [29] Evaluation of Annona muricata Acetogenins as Potential Anti-SARS-CoV-2 Agents Through Computational Approaches
    Prasad, Shashanka K.
    Pradeep, Sushma
    Shimavallu, Chandan
    Kollur, Shiva Prasad
    Syed, Asad
    Marraiki, Najat
    Egbuna, Chukwuebuka
    Gaman, Mihnea-Alexandru
    Kosakowska, Olga
    Cho, William C.
    Patrick-Iwuanyanwu, Kingsley Chukwuemeka
    Ortega Castro, Joaquin
    Frau, Juan
    Flores-Holguin, Norma
    Glossman-Mitnik, Daniel
    FRONTIERS IN CHEMISTRY, 2021, 8
  • [30] De Novo design of potential inhibitors against SARS-CoV-2 Mpro
    Li, Shimeng
    Wang, Lianxin
    Meng, Jinhui
    Zhao, Qi
    Zhang, Li
    Liu, Hongsheng
    COMPUTERS IN BIOLOGY AND MEDICINE, 2022, 147
12345